Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REHAB Basel is a Swiss specialty rehabilitation clinic focused on neurorehabilitation and paraplegiology for patients with brain injuries and spinal cord injuries caused by accident or illness. The organization provides highly specialized inpatient, day-clinic, and outpatient services, with an interdisciplinary care model spanning early rehabilitation through longer-term recovery and reintegration. Its clinical scope includes care for paraplegia, disorders of consciousness, neurological rehabilitation, neurourology, spasticity, pain, and related complications, as well as selected conditions such as cerebral palsy, amyotrophic lateral sclerosis, multiple sclerosis, and central nervous system tumors. REHAB Basel also participates in clinical and outcomes research, including studies such as SwiSCI and REACT, and operates as a non-profit healthcare institution rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REHAB Basel.